Michael Brooks
Chief Operating Officer chez SYNEOS HEALTH, INC.
Profil
Michael Brooks is currently the Director at the North Carolina State University College of Sciences Foundation.
He is also the Chief Operating Officer at Syneos Health, Inc. starting in 2022.
Previously, he held positions such as President-Clinical Development & Commercialization at Laboratory Corp.
of America Holdings, President & Global Head-Clinical Development at Labcorp Drug Development, Inc. from 2019 to 2020, and Executive VP & Global Head-Clinical Development at PRA Health Sciences, Inc. from 2015 to 2018.
Mr. Brooks obtained his undergraduate degree from North Carolina State University.
Postes actifs de Michael Brooks
| Sociétés | Poste | Début |
|---|---|---|
| SYNEOS HEALTH, INC. | Chief Operating Officer | 29/04/2022 |
| North Carolina State University College of Sciences Foundation | Director/Board Member | - |
Anciens postes connus de Michael Brooks
| Sociétés | Poste | Fin |
|---|---|---|
| COVANCE INC. | President | 01/11/2020 |
| PRA HEALTH SCIENCES, INC. | Corporate Officer/Principal | 01/11/2018 |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Corporate Officer/Principal | - |
Formation de Michael Brooks
| North Carolina State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
| Entreprise privées | 4 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
PRA Health Sciences, Inc.
 PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights, and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC. | Commercial Services |
| North Carolina State University College of Sciences Foundation | |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
